Dr. Hank Agersborg is Clinuvel’s Chief Scientific Officer. With over 50 years working in the industry, his insights and experience span some of the most dynamic and exciting eras of change and evolution that this sector has seen.
In this interview he shares with us his views on novel and designer drugs and the fundamental shifts that have occurred in pharmaceutical development.
Click here to listen or download.
